↑ Kaye WH, Frank GK, Bailer UF, Henry SE (2005). «Neurobiology of anorexia nervosa: clinical implications of alterations of the function of serotonin and other neuronal systems». The International Journal of Eating DisordersSuppl (S1): S15–9; discussion S20–1. DOI:10.1002/eat.20109. PMID 15852312.
↑ Bergen AW, Yeager M, Welch RA, et al. (September 2005). «Association of multiple DRD2 polymorphisms with anorexia nervosa». Neuropsychopharmacology30 (9): 1703–10. DOI:10.1038/sj.npp.1300719. PMID 15920508.
↑ Kaye WH. et al. (April 2006). «Persistent alterations of serotonin and dopamine activity after recovery from anorexia and bulimia nervosa». Psychosomatic Medicine1287: 45–48. DOI:10.1016/j.ics.2005.12.038.
↑ Bosanac P, Norman T, Burrows G, Beumont P (March 2005). «Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics?». The Australian and New Zealand Journal of Psychiatry39 (3): 146–53. DOI:10.1111/j.1440-1614.2005.01536.x. PMID 15701063.
↑ Симптомы и синдромы в эндокринологии / Под ред. Ю. И. Караченцева. — 1-е изд. — Х.: ООО «С.А.М.», Харьков, 2006. — С. 81. — 227 с. — (Справочное пособие). — 1000 экз. — ISBN 978-966-8591-14-3